Cargando…
In vivo Prevention of Transplant Arteriosclerosis by ex vivo Expanded Human Regulatory T Cells
Transplant arteriosclerosis (TA) is the hallmark of chronic allograft dysfunction (CAD) affecting transplanted organs in the long term [1,2]. These fibroproliferative lesions lead to neointimal thickening of arteries in all transplanted allografts [2]. Luminal narrowing then leads to graft ischemia...
Autores principales: | Nadig, Satish N., Więckiewicz, Joanna, Wu, Douglas C., Warnecke, Gregor, Zhang, Wei, Luo, Shiqiao, Schiopu, Alexandru, Taggart, David P., Wood, Kathryn J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929438/ https://www.ncbi.nlm.nih.gov/pubmed/20473306 http://dx.doi.org/10.1038/nm.2154 |
Ejemplares similares
-
Low-Dose Rapamycin Treatment Increases the Ability of Human Regulatory T Cells to Inhibit Transplant Arteriosclerosis In Vivo
por: Hester, J, et al.
Publicado: (2012) -
Inflammatory Ly-6C(hi) monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients
por: Schiopu, Alexandru, et al.
Publicado: (2012) -
Ex Vivo Expanded Human Regulatory T Cells Can Prolong Survival of a Human Islet Allograft in a Humanized Mouse Model
por: Wu, Douglas C., et al.
Publicado: (2013) -
Extracellular Vesicles Derived From Ex Vivo Expanded Regulatory T Cells Modulate In Vitro and In Vivo Inflammation
por: Thome, Aaron D., et al.
Publicado: (2022) -
A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants
por: Mathew, James M., et al.
Publicado: (2018)